# Lisata Therapeutics, Inc.: Form 8-K, filed Feb 18, 2022

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 8-K
- Filed: 2022-02-18
- Accepted by EDGAR: Feb 18, 2022, 16:47 ET
- Period: 2022-02-18
- Accession: 0000320017-22-000005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000032001722000005/clbs-20220218.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000032001722000005/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000032001722000005/clbs-20220218.htm

Filed Feb 18, 2022.
Source: SEC EDGAR, the filing index for accession 0000320017-22-000005. Last ingested by Listed: Nov 14, 2026, 19:21 ET. No prices; not investment advice.
